The deprescribing debate The AJP Podcast
-
- Business
Our latest podcast looks at deprescribing. Where do pharmacists’ responsibilities lie? What are the risks and benefits?
In this podcast, host Carlene McMaugh speaks to a diverse range of pharmacists to examine the state of play around deprescribing, and where the profession’s role current sits, and where should it be?
Among those in the podcast are:
Rachel Dienaar and Peter Crothers speaking about adverse events, discussing deprescribing with elderly patients and ensuring deprescribing is a means to an end, and not an end itself
Amy Page discusses the role of polypharmacy
Steve Morris talks about the challenges in talking to patients about deprescribing, and the need for support
Amanda Cross looks at the barriers to deprescribing, the evidence to support it, and where it sits on the prescribing continuum
Go here for the full list of active AJP podcasts. These can also be accessed via Google Podcasts, Apple Podcasts and Spotify
Carlene McMaugh, AJP podcast host
Our latest podcast looks at deprescribing. Where do pharmacists’ responsibilities lie? What are the risks and benefits?
In this podcast, host Carlene McMaugh speaks to a diverse range of pharmacists to examine the state of play around deprescribing, and where the profession’s role current sits, and where should it be?
Among those in the podcast are:
Rachel Dienaar and Peter Crothers speaking about adverse events, discussing deprescribing with elderly patients and ensuring deprescribing is a means to an end, and not an end itself
Amy Page discusses the role of polypharmacy
Steve Morris talks about the challenges in talking to patients about deprescribing, and the need for support
Amanda Cross looks at the barriers to deprescribing, the evidence to support it, and where it sits on the prescribing continuum
Go here for the full list of active AJP podcasts. These can also be accessed via Google Podcasts, Apple Podcasts and Spotify
Carlene McMaugh, AJP podcast host
30 min